UBS Group »

Heron Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Heron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Heron Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Heron Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $207k 122k 1.70
2023-09-30 $65k 63k 1.03
2023-06-30 $80k 69k 1.16
2023-03-31 $84k 56k 1.51
2022-12-31 $92k 37k 2.50
2022-09-30 $376k 88k 4.28
2022-06-30 $22k 8.1k 2.73
2022-03-31 $1.3M 234k 5.69
2021-12-31 $2.9M 319k 9.18
2021-09-30 $2.6M 248k 10.67
2021-06-30 $126k 8.1k 15.53
2021-03-31 $2.4M 148k 16.21
2020-12-31 $2.8M 132k 21.16
2020-09-30 $1.4M 92k 14.82
2020-06-30 $1.7M 114k 14.71
2020-03-31 $1.5M 125k 11.74
2019-12-31 $2.3M 99k 23.37
2019-09-30 $4.5M 241k 18.50
2019-06-30 $3.3M 180k 18.60
2019-03-31 $1.4M 57k 24.43
2018-12-31 $5.3M 205k 25.94
2018-09-30 $2.7M 87k 31.65
2018-06-30 $2.0M 52k 38.86
2018-03-31 $6.0M 219k 27.61
2017-12-31 $713k 39k 18.08
2017-09-30 $734k 46k 16.14
2017-06-30 $423k 31k 13.86
2017-03-31 $173k 12k 15.01
2016-12-31 $585k 45k 13.10
2016-09-30 $155k 9.0k 17.23
2016-06-30 $3.8M 206k 18.57
2016-03-31 $2.6M 140k 18.57
2015-12-31 $9.4M 351k 26.70
2015-09-30 $7.6M 312k 24.40
2015-03-31 $21k 1.4k 14.60